Increased lactate in AML blasts upregulates TOX expression, leading to exhaustion of CD8+ cytolytic T cells.
Year: 2021
Type: article
Abstract: TEMRA cells and PD-1 expression, and increased perforin and granzyme B. However, no difference was found in the relapsed patients. The study presented here has established lactate as a predictive biomarker for patient response to antitumor therapies and demonstrated that targeting this gene in AML patients could be a meaningful precision therapeutic strategy.
Source: PubMed
Authors: Ying Chen, Zhongxin Feng, Xingyi Kuang, Peng Zhao, Bingqing Chen, Qin Fang, Weiwei Cheng, Jishi Wang
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4206846894
